Published in TB and Outbreaks Week, September 23rd, 2003
In a recent study from New York, the use of GAT "in combination with ethionamide (ETA) with or without pyrazinamide (PZA) for a 12-week treatment period followed by an 8-week observation period was evaluated in a model of tuberculosis in mice."
"Mice treated with GAT at 300 mg/kg of body weight in combination with ETA (25 mg/kg) for five days per week had sterile lungs, whereas mice treated with GAT (100 mg/kg) and ETA (25 mg/kg) had about 10 CFU/lung," reported M.H. Cynamon and coauthors at the Veterans Affairs Medical Center in Syracuse. However, "there was regrowth of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.